Q4 2019 Protalix Biotherapeutics Inc Earnings Call Transcript
Greetings, and welcome to the Protalix Biopharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial and Business Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Monique Kosse, Investor Relations at LifeSci Advisors. Thank you. You may begin.
Thank you, operator, and welcome, everyone. Thank you for joining us today for a discussion of Protalix' Fourth Quarter and Full Year 2019 Financial Results. Leading the call today will be Dror Bashan, President and Chief Executive Officer of Protalix. He will be joined by Eyal Rubin, Chief Financial Officer of Protalix.
Before we begin, I would like to remind everyone that various statements made during this call will include forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include those regarding the company's future plans, prospects and strategy,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |